X T L Biopharmaceuticals reported $-254K in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 1.29M 865K Mar/2026
Bioline Rx USD 20.83M 2.64M Mar/2026
Teva Pharmaceutical Industries USD 7.75B 475M Jun/2026
X T L Biopharmaceuticals USD -254K 207K Dec/2025